Not Rated
Fund Size
(0.78% of Investment in Category)
|
Expense Ratio
(2.1% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 08-Oct-25 | 10126.50 | 1.26% | - | 1.04% | 160/239 |
1 Month | 15-Sep-25 | 9973.30 | -0.27% | - | 0.35% | 147/236 |
3 Month | 15-Jul-25 | 9849.90 | -1.50% | - | 1.06% | 191/227 |
6 Month | 15-Apr-25 | 10589.30 | 5.89% | - | 11.69% | 205/224 |
YTD | 01-Jan-25 | 9892.50 | -1.07% | - | 3.62% | 149/213 |
1 Year | 15-Oct-24 | 10200.20 | 2.00% | 2.00% | -1.08% | 53/196 |
2 Year | 13-Oct-23 | 15521.40 | 55.21% | 24.47% | 18.70% | 17/152 |
3 Year | 14-Oct-22 | 19763.10 | 97.63% | 25.44% | 20.11% | 21/127 |
5 Year | 15-Oct-20 | 24359.20 | 143.59% | 19.48% | 22.44% | 66/103 |
10 Year | 15-Oct-15 | 28294.90 | 182.95% | 10.95% | 14.06% | 69/76 |
Since Inception | 31-Jul-99 | 562277.00 | 5522.77% | 16.61% | 12.66% | 86/216 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 15-Oct-24 | 12000 | 12405.59 | 3.38 % | 6.33 % |
2 Year | 13-Oct-23 | 24000 | 27917.42 | 16.32 % | 15.26 % |
3 Year | 14-Oct-22 | 36000 | 50036.54 | 38.99 % | 22.57 % |
5 Year | 15-Oct-20 | 60000 | 99158.11 | 65.26 % | 20.19 % |
10 Year | 15-Oct-15 | 120000 | 302505.71 | 152.09 % | 17.59 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 4304.6 | 10.94% | 0.08% | 13.98% (Apr 2025) | 10.86% (Aug 2025) | 27.00 L | 0.00 |
Divis Laboratories Ltd. | Pharmaceuticals | 2503.4 | 6.36% | -0.45% | 7.78% (Jun 2025) | 6% (Mar 2025) | 4.40 L | 0.00 |
Max Healthcare Institute Ltd. | Hospital | 2229.4 | 5.67% | -0.45% | 6.96% (Jun 2025) | 5.66% (Nov 2024) | 20.00 L | -1.00 L |
Cipla Ltd. | Pharmaceuticals | 1804 | 4.59% | -0.22% | 5.9% (Dec 2024) | 4.54% (Oct 2024) | 12.00 L | 0.00 |
Lupin Ltd. | Pharmaceuticals | 1605.5 | 4.08% | 0.06% | 5.19% (Dec 2024) | 4.02% (Aug 2025) | 8.40 L | 0.00 |
Lonza Group AG | Foreign equity | 1597.6 | 4.06% | -0.18% | 5% (Feb 2025) | 4.06% (Sep 2025) | 2.70 L | 0.00 |
Fortis Healthcare Ltd. | Hospital | 1454.7 | 3.70% | 0.25% | 3.7% (Sep 2025) | 2.19% (Oct 2024) | 15.00 L | 0.00 |
Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 1441.3 | 3.66% | 0.07% | 3.66% (Sep 2025) | 2.58% (May 2025) | 4.00 L | 0.00 |
Gland Pharma Ltd. | Pharmaceuticals | 1394.1 | 3.54% | 0.23% | 3.59% (Jul 2025) | 2.06% (Apr 2025) | 7.00 L | 0.00 |
Mankind Pharma Ltd. | Pharmaceuticals | 1315.3 | 3.34% | -0.15% | 4.15% (Dec 2024) | 2.96% (Nov 2024) | 5.40 L | -0.20 L |
Investment / Portfolio Grades
Security Type |
% Weight |
Category Average |
---|---|---|
Government Backed | 0.08% | 0.37% |
Low Risk | 0.00% | 0.00% |
Moderate Risk | 0.00% | 0.00% |
High Risk | 0.00% | 0.00% |
Very High Risk | 0.00% | 0.00% |
Others | 0.00% | 0.00% |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 3.85% |
Net Receivables | Net Receivables | -0.29% |
Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)
Out of 140 mutual fund schemes offered by this AMC, 3 is/are ranked 5 * , 7 is/are ranked 4 * , 12 is/are ranked 3 * , 7 is/are ranked 2 * , 8 is/are ranked 1 * , and 103 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
SBI Nifty 50 ETF | 4 | 202457.72 | 1.37 | 1.79 | 10.08 | 3.71 | 15.39 |
SBI Nifty 50 ETF | 4 | 202457.72 | 1.37 | 1.79 | 10.08 | 3.71 | 15.39 |
SBI BSE Sensex ETF | 5 | 117106.13 | 1.33 | 1.26 | 9.29 | 3.61 | 14.26 |
SBI BSE Sensex ETF | 5 | 117106.13 | 1.33 | 1.26 | 9.29 | 3.61 | 14.26 |
SBI Equity Hybrid Fund - Regular Plan - Growth | 3 | 79008.05 | 1.96 | 1.58 | 9.94 | 9.20 | 14.96 |
SBI Liquid Fund - Regular Plan - Growth | 3 | 56928.87 | 0.47 | 1.39 | 2.96 | 6.64 | 6.93 |
SBI Large Cap Fund - Regular Plan - Growth | 3 | 52829.93 | 0.59 | 0.92 | 9.31 | 1.52 | 15.61 |
SBI Contra Fund - Regular Plan - Growth | 4 | 47205.42 | 0.36 | -0.86 | 7.33 | -2.53 | 21.00 |
SBI Arbitrage Opportunities Fund - Regular Plan - Growth | 4 | 39217.39 | 0.53 | 1.33 | 2.91 | 6.72 | 7.16 |
SBI Focused Fund - Regular Plan - Growth | 4 | 38916.82 | 1.03 | 3.18 | 11.26 | 7.25 | 16.75 |